Sarepta Elevidys Shipments - Search News

Order byBest matchMost fresh

News

Sarepta stops Elevidys shipments

· 18m · on MSN

Sarepta to pause Elevidys gene therapy shipments in U.S.

Sarepta Therapeutics (NASDAQ:SRPT) said late Monday it will pause all shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, in the U.S. The development comes after Sarepta declined to halt shipments of its Elevidys gene therapy,

Continue reading

GEN - Genetic Engineering and Biotechnology News · 3h

About Face: Sarepta to Pause Elevidys Shipments Temporarily

Sarepta stops Elevidys shipments after standoff with FDA

Sarepta Suspends Gene Therapy Shipments After Tragic Deaths

Sarepta Therapeutics has paused U.S. shipments of its gene therapy Elevidys after two teenagers with Duchenne muscular ...

13h

Sarepta Therapeutics stock sinks after FDA tells company to stop shipping its bestselling drug

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results